AtriCure, Inc. — Director's Dealing 2012

Oct 26, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-10-25

Reporting Person: LUX ANDREW L (V.P. & Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-25	Stock Option (right to buy)	$6.27	A	30000	Acquired	2022-10-25	Common Stock (30000)	Direct

Footnotes

F1: The option vests and is exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

F2: Not applicable